CFCL – Future growth engine
* CLEAN’s R&D, focused on innovation and sustainability, achieved key milestones in FY24, including the commercialization of HALS series and the development of pharma intermediates. Currently, there are 10 new molecules in progress, which should drive future growth in the pharmaceuticals, polymers, and sustainable agrochemicals segments of the company.
* Clean Fino Chem (CFCL), a wholly owned subsidiary of CLEAN, is scaling up HALS production ...
Neutral Clean Science & Technology Ltd For Target Rs. 1,580 By Motilal Oswal Financial Services Ltd